Last reviewed · How we verify
d-amphetamine
At a glance
| Generic name | d-amphetamine |
|---|---|
| Also known as | dextroamphetamine sulfate, sustained release d-amphetamine, dexedrine, Dexedrine |
| Sponsor | Biotie Therapies Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery (PHASE4)
- Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia (PHASE2)
- 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression (PHASE2)
- [C-11]NPA PET-amphetamine in Cocaine Use Disorders (EARLY_PHASE1)
- Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds (PHASE2)
- MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder (PHASE2)
- The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD (NA)
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |